MedTrace Logo

Serum Endocan Levels in Polycystic Ovary Syndrome

NCT03019679 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 175

Last updated 2021-02-01

No results posted yet for this study

Summary

In this study the investigators aimed to investigate whether there is a relation between polycystic ovary syndrome and serum endocan levels.

Conditions

  • Polycystic Ovary Syndrome

Sponsors & Collaborators

  • Tokat Gaziosmanpasa University

    lead OTHER

Principal Investigators

  • Ilhan B Delibas, M.D. · Gaziosmanpasa University Department of Obstetrics and Gynecology

  • Esra Laloglu, M.D. · Erzurum Halk Saglıgı Laboratuvarı

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2017-04-30
Completion
2017-04-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03019679 on ClinicalTrials.gov